Please ensure Javascript is enabled for purposes of website accessibility


Recommendation : Patient prioritization regarding the disposal of therapeutic means against COVID-19 (monoclonal antibodies)

Recommendation : "Patient prioritization regarding the disposal fo therapeutic means against COVID-19 (monoclonal antibodies)"

Athens, 18 December 2021

The NCBT discussed the issue of treatment prioritization for coronavirus, following a relevant request and accompanying note from the Ministry of Health.

The issue has occurred due to the availability of monoclonal antibody therapy in a limited number of doses, compared to the number of potential recipients among confirmed cases of the disease in the population.

It must be noted that the monoclonal antibody therapy is only suitable for the early stages of COVID-19, before the patient’s possible hospitalization. This expands the circle of potential recipients in large groups of the population, which makes prioritization a particularly complex problem.



The Commission offers to students, mostly postgraduates, both from human and life sciences the Possibility of training on issues related to bioethics

More information
Educational Seminars

The Commission organizes educational seminars covering a wide range of bioethics issues

More information
Bioethics go to school

The Commission organizes educational activities for schools (Secondary Schools and High Schools) related to bioethics

More information